Researchers from Weill Cornell Medicine and the Burke Neurological Institute have developed a new drug that could make a big difference for people suffering from chronic nerve pain. This condition, ...

Lower back pain is a common issue that affects around 8 out of 10 people at some point in their lives. Researchers are now ...

The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...

Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be Presented at the Pain Therapeutics Summit in Boston MIAMI, FL ...

Insect venom may seem like an unlikely ally in the discovery of new human pain treatments, but the latest findings into the ...

Thousands of bottles of a commonly prescribed antidepressant drug were recalled because they contained a suspected cancer-causing chemical.

Thousands of bottles of an antidepressant have been recalled by the U.S. Food and Drug Administration due to a cancerous ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

According to OKYO Pharma, OK-101 is the first drug candidate to enroll patients specifically diagnosed with neuropathic ...

In 2020, an estimated 54 million adults in the U.S. were living with chronic pain. Over 25 percent of them were treating ...

Zen types will tell you to accept the itch, to meditate on it, as you might do if you were in pain. These people have no idea ...